Wednesday, October 30, 2019 /4:23 PM / By NSE / Header Image Credit: GSK
Glaxosmithkline Consumer Nigeria Plc released its Q3 unaudited 2019 results for the period ended September 30th, 2019.
Revenue grew by 13.9% to N15.92bn from N13.97bn in the previous quarter.
Profit before tax grew by 20.88% to N613m.
Profit after tax grew by 21.33% to N427m.
Net Assets also declined by 1.94% to N8.66bn from N8.83bn as at December 31, 2018.
Visit Glaxosmithkline Consumer Nigeria Plc IR Page in Proshare MARKETS